Concepedia

Young-Kwon Kim

YK

Statistics

Publications

8

Citations

759

H-Index

8

Active since

2010

Affiliations

Hôpital Bichat-Claude-Bernard(Current)

Auckland City Hospital

SUNY Downstate Health Sciences University

Université Paris Cité

Leiden University Medical Center

Young-Kwon Kim is an author at Hôpital Bichat-Claude-Bernard specializing in medicine, cardiovascular disease, and cardiovascular pharmacotherapy.

ORCID

Publications per year

2010–2022

8

Publications

8

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

Relationship Between Serum Uric Acid Levels, Metabolic Syndrome, and Arterial Stiffness in Korean

Ji Hyon Lim, Young-Kwon Kim, Yong‐Seok Kim et al. · Korean Circulation Journal · 2010 · 79 citations · Full text

, , +13

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 38 citations · Full text

, , +17

1–5 of 8